Brio Consultants’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,298
Closed -$222K 92
2022
Q3
$222K Sell
1,298
-20
-2% -$3.38K 0.05% 88
2022
Q2
$231K Buy
1,318
+22
+2% +$3.92K 0.05% 74
2022
Q1
$230K Buy
+1,296
New +$221K 0.05% 72
2021
Q4
Sell
-3,468
Closed -$560K 75
2021
Q3
$560K Buy
3,468
+262
+8% +$44.7K 0.14% 48
2021
Q2
$528K Buy
3,206
+21
+0.7% +$3.48K 0.13% 48
2021
Q1
$523K Buy
3,185
+20
+0.6% +$3.24K 0.15% 45
2020
Q4
$498K Sell
3,165
-54
-2% -$7.97K 0.16% 43
2020
Q3
$479K Sell
3,219
-366
-10% -$54.2K 0.14% 46
2020
Q2
$504K Buy
3,585
+22
+0.6% +$3.21K 0.17% 43
2020
Q1
$467K Buy
3,563
+21
+0.6% +$2.98K 0.19% 45
2019
Q4
$517K Buy
3,542
+21
+0.6% +$2.85K 0.17% 47
2019
Q3
$456K Buy
3,521
+417
+13% +$54.9K 0.17% 46
2019
Q2
$432K Sell
3,104
-101
-3% -$14K 0.17% 45
2019
Q1
$448K Buy
3,205
+47
+1% +$6.3K 0.2% 43
2018
Q4
$408K Buy
+3,158
New +$441K 0.21% 45

Other funds holding JNJ

Brio Consultants's JNJ Position: Q4 2022 in Review

Brio Consultants sold out of Johnson & Johnson (JNJ) in Q4 2022, closing a stake of 1,298 shares — an estimated $222K sold.

Brio Consultants first reported a position in JNJ in Q4 2018 and held it in 15 quarters. The position peaked at $560K in Q3 2021. 3,788 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Brio Consultants reported no remaining Johnson & Johnson position as of Q4 2022 after selling out during the quarter.
  • Brio Consultants sold 1,298 Johnson & Johnson shares in Q4 2022, an estimated $222K.
  • Brio Consultants first reported a position in Johnson & Johnson in Q4 2018 and held it in 15 quarters.
  • Brio Consultants's Johnson & Johnson position peaked at $560K in Q3 2021.
  • 3,788 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Brio Consultants's 13F filing for Q4 2022, filed 7 Feb 2023.